Yifan Xinfu Pharmaceutical Co Ltd002019
▲ PositiveCapitalrelevance
Company repurchased shares, signaling confidence and supporting stock price.

Yifan Pharmaceutical announced that as of July 31, 2026, the company had repurchased 5 million shares, accounting for 0.41% of total share capital, with a total repurchase amount of 53.94 million yuan and a repurchase price range of 10.54 yuan to 11.04 yuan per share. In the first quarter of 2026, the company achieved revenue of 1.256 billion yuan and net profit attributable to the parent of 107 million yuan.
Yifan Xinfu Pharmaceutical Co LtdCompany repurchased shares, signaling confidence and supporting stock price.